迷你医疗集团 MMED
$16.71 −$1.45 (-7.96%)
休市 · Nov 6, 8:20 pm ET · 最新盘后价 $16.75 +0.24%
开盘$18.25
昨收$18.16
当日区间$16.66 – $18.25
成交量7.48M
市值$4.70B
市盈率（TTM）–
股息率–
基本面
最新报告季度：Q1, ended Jul 2026
营收$843.00M+16.6% YoY
营业利润$2.00M-33.3% YoY
净利润$0.00+100.0% YoY
摊薄每股收益$0.00+100.0% YoY
自由现金流-$90.00M+53.6% YoY
经营现金流-$49.00M
营收，近7个季度
净利润，近7个季度
各季度摊薄每股收益
各季度自由现金流
年度营收
盈利能力与资产负债表
毛利率53.9%
营业利润率-5.0%
净利率-9.7%
净资产收益率-8.7%
资产收益率-6.7%
投入资本回报率-8.7%
流动比率1.81
负债/资产比率23.3%
现金及投资$207.00M
净现金（净负债）$207.00M
营收构成
2027/Q1 季度
按业务线
资产负债表
| 项目 | 2027 Q1 | 2026 ANNUAL | 2026 Q4 | 2026 Q3 | 2026 Q2 |
|---|---|---|---|---|---|
| 股东权益 | $3.62B | $3.61B | $3.61B | $3.46B | $3.74B |
| 其他非流动资产 | $152.00M | $147.00M | $147.00M | $146.00M | $150.00M |
| -其他无形资产 | $99.00M | $106.00M | $106.00M | $112.00M | $119.00M |
| -商誉 | $2.26B | $2.26B | $2.26B | $2.26B | $2.26B |
| 商誉及其他无形资产 | $2.35B | $2.36B | $2.36B | $2.37B | $2.38B |
| 一年以上应收账款 | $58.00M | $61.00M | $61.00M | $19.00M | $64.00M |
| 固定资产净值 | $736.00M | $711.00M | $711.00M | $701.00M | $755.00M |
| 非流动资产合计 | $3.30B | $3.28B | $3.28B | $3.23B | $3.34B |
| 其他流动资产 | $72.00M | $54.00M | $54.00M | $38.00M | $13.00M |
| 存货 | $356.00M | $341.00M | $341.00M | $407.00M | $362.00M |
| -一年内应收关联方款项 | $602.00M | $455.00M | $455.00M | – | – |
| -应收账款 | $180.00M | $200.00M | $200.00M | $653.00M | $166.00M |
| 负债合计 | $1.10B | $1.02B | $1.02B | $880.00M | $491.00M |
| 流动负债合计 | $782.00M | $702.00M | $702.00M | $696.00M | $350.00M |
| 股东权益合计 | $3.62B | $3.61B | $3.61B | $3.46B | $3.74B |
| 其他非流动负债 | $316.00M | $317.00M | $317.00M | $184.00M | $141.00M |
| 非流动负债合计 | $316.00M | $317.00M | $317.00M | $184.00M | $141.00M |
| 其他流动负债 | -$1.00M | $1.00M | $1.00M | -$1.00M | -$1.00M |
| 一年内递延负债 | $14.00M | $15.00M | $15.00M | $13.00M | – |
| -一年内到期融资租赁负债 | $9.00M | $8.00M | $8.00M | $11.00M | – |
| 一年内应计费用 | $129.00M | $177.00M | $177.00M | $186.00M | $128.00M |
| -一年内应付关联方款项 | $178.00M | – | – | – | – |
| -应付税款合计 | $76.00M | $38.00M | $38.00M | – | – |
| -应付账款 | $251.00M | $163.00M | $163.00M | $303.00M | $129.00M |
| 应付款 | $505.00M | $201.00M | $201.00M | $303.00M | $129.00M |
| 应收款 | $782.00M | $655.00M | $655.00M | $653.00M | $166.00M |
| -现金及现金等价物 | $207.00M | $298.00M | $298.00M | $10.00M | $350.00M |
| 现金及现金等价物与短期投资 | $207.00M | $298.00M | $298.00M | $10.00M | $350.00M |
| 流动资产合计 | $1.42B | $1.35B | $1.35B | $1.11B | $891.00M |
| 总资产 | $4.72B | $4.63B | $4.63B | $4.34B | $4.24B |
| 股本 | $3.00M | $3.00M | $3.00M | – | $3.00M |
| -普通股 | $3.00M | $3.00M | $3.00M | – | $3.00M |
| -优先股 | $0.00 | $0.00 | $0.00 | – | – |
| 留存收益 | -$116.00M | -$116.00M | -$116.00M | – | -$5.00M |
| 短期债务及融资租赁负债 | $9.00M | $145.00M | $145.00M | $11.00M | – |
| 不影响留存收益的损益 | -$14.00M | -$12.00M | -$12.00M | $14.00M | $8.00M |
| 资本公积 | $3.75B | $3.74B | $3.74B | – | $3.74B |
| -累计折旧 | – | -$781.00M | -$781.00M | – | – |
| -固定资产原值 | – | $1.49B | $1.49B | – | – |
| 少数股东权益 | – | $0.00 | $0.00 | – | – |
| -一年内到期债务 | – | $137.00M | $137.00M | – | – |
| 其他权益权益 | – | – | – | $3.45B | – |
现金流量表
| 项目 | 2027 Q1 | 2026 Q4 | 2026 ANNUAL | 2026 Q3 | 2026 Q2 |
|---|---|---|---|---|---|
| -应付账款及应计费用变动 | $78.00M | $204.00M | $178.00M | $126.00M | $19.00M |
| -存货变动 | -$15.00M | $64.00M | -$29.00M | -$43.00M | -$20.00M |
| -应收款变动 | -$148.00M | -$444.00M | -$538.00M | -$74.00M | -$15.00M |
| 营运资金变动 | -$110.00M | $12.00M | -$166.00M | $22.00M | -$12.00M |
| 其他非现金项目 | $2.00M | $3.00M | $19.00M | $4.00M | $2.00M |
| 递延税款 | $2.00M | -$55.00M | -$54.00M | – | – |
| 折旧、折耗与摊销 | $41.00M | $39.00M | $156.00M | $39.00M | $39.00M |
| 持续经营净利润 | $0.00 | -$185.00M | -$317.00M | -$111.00M | -$5.00M |
| 持续经营经营活动现金流净额 | -$50.00M | -$171.00M | -$197.00M | $67.00M | $47.00M |
| 经营活动现金流 | -$49.00M | -$170.00M | -$197.00M | $66.00M | $48.00M |
| -其他营运资金变动 | -$25.00M | $31.00M | $66.00M | $13.00M | $4.00M |
| 投资活动现金流净额 | -$41.00M | -$56.00M | -$233.00M | -$53.00M | -$61.00M |
| 自由现金流 | -$90.00M | -$226.00M | -$420.00M | $13.00M | -$13.00M |
| 汇率变动影响 | -$1.00M | – | $1.00M | – | – |
| 期初现金余额 | $298.00M | $10.00M | $11.00M | $8.00M | $9.00M |
| 现金净变动 | -$90.00M | $287.00M | $286.00M | $2.00M | -$1.00M |
| 期末现金余额 | $207.00M | $298.00M | $298.00M | $10.00M | $8.00M |
| 持续经营筹资活动现金流净额 | $0.00 | $512.00M | $716.00M | -$11.00M | $13.00M |
| 筹资活动现金流 | $0.00 | $512.00M | $716.00M | -$11.00M | $13.00M |
| 固定资产购置及出售净额 | -$41.00M | -$56.00M | -$223.00M | -$53.00M | -$61.00M |
| 持续经营投资活动现金流净额 | -$41.00M | -$56.00M | -$233.00M | -$53.00M | -$61.00M |
| 其他投资变动净额 | – | $0.00 | -$10.00M | $0.00 | $0.00 |
| 其他筹资费用净额 | – | -$26.00M | $178.00M | -$11.00M | $13.00M |
| 持续经营损益 | – | $1.00M | $7.00M | $2.00M | $2.00M |
| -其他流动负债变动 | – | – | $157.00M | – | – |
| 普通股发行净额 | – | – | $538.00M | – | – |
| 投资购置及出售净额 | – | – | $0.00 | – | – |
利润表
| 项目 | 2027 Q1 | 2026 ANNUAL | 2026 Q4 | 2026 Q3 | 2026 Q2 |
|---|---|---|---|---|---|
| 基本每股收益 | $0.00 | -$1.30 | -$0.66 | -$0.42 | -$0.10 |
| 归属母公司净利润 | $0.00 | -$333.00M | -$185.00M | -$119.00M | -$27.00M |
| 归属普通股股东净利润 | $0.00 | -$333.00M | -$185.00M | -$119.00M | -$27.00M |
| 摊薄每股收益 | $0.00 | -$1.30 | -$0.66 | -$0.42 | -$0.10 |
| 少数股东权益 | $0.00 | $16.00M | $0.00 | $8.00M | -$3.00M |
| 持续经营利润 | $0.00 | -$317.00M | -$185.00M | -$111.00M | -$31.00M |
| 净利润 | $0.00 | -$317.00M | -$185.00M | -$111.00M | -$30.00M |
| 税费 | $4.00M | $128.00M | $93.00M | $12.00M | $19.00M |
| 税前利润 | $4.00M | -$189.00M | -$92.00M | -$99.00M | -$12.00M |
| -减：其他特殊支出 | -$2.00M | $18.00M | $7.00M | -$6.00M | $0.00 |
| 营业费用 | $463.00M | $1.84B | $567.00M | $455.00M | $438.00M |
| 营业成本 | $378.00M | $1.42B | $357.00M | $428.00M | $324.00M |
| 营业总收入 | $843.00M | $3.10B | $837.00M | $790.00M | $752.00M |
| 报告营业总收入 | $843.00M | $3.10B | $837.00M | $790.00M | $752.00M |
| 特殊收益（费用） | $2.00M | -$31.00M | -$6.00M | -$7.00M | $0.00 |
| 毛利润 | $465.00M | $1.68B | $480.00M | $362.00M | $428.00M |
| 销售及管理费用 | $312.00M | $1.18B | $299.00M | $309.00M | $318.00M |
| 研发费用 | $115.00M | $448.00M | $99.00M | $114.00M | $111.00M |
| 其他收入（支出） | $2.00M | -$30.00M | -$5.00M | -$7.00M | -$1.00M |
| 营业利润 | $2.00M | -$159.00M | -$87.00M | -$93.00M | -$10.00M |
| 其他营业费用 | $36.00M | $208.00M | $169.00M | $32.00M | $9.00M |
| -销售及营销费用 | – | $1.18B | $299.00M | $309.00M | – |
| 其他非经营性收入（支出） | – | $1.00M | – | – | – |
| -减：重组及并购费用 | – | $13.00M | -$1.00M | $13.00M | – |
暂无评论——快来第一个聊聊 MMED。
登录后参与讨论。